Assignee
PERALTA CANCER RESEARCH INST
US·5 granted patents·136 citations·filing 1985–1990
Top patents by PatentIndex Score
5 records- 0184US4816395AMethod for predicting chemosensitivity of anti-cancer drugsPERALTA CANCER RESEARCH INST·Filed 1985·Granted Mar 28, 1989·61 cites·18 claims
- 0270US4937182AMethod for predicting chemosensitivity of anti-cancer drugsPERALTA CANCER RESEARCH INST·Filed 1989·Granted Jun 26, 1990·30 cites·18 claims
- 0362US5225541AComposition containing CEA/NCA-specific monoclonal antibody XMMBR-B14 conjugated to a detectable moiety and a kit containing the antibodyPERALTA CANCER RESEARCH INST·Filed 1989·Granted Jul 6, 1993·30 cites·2 claims
- 0444US5158893AMethods and compositions for screening carcinomasPERALTA CANCER RESEARCH INST·Filed 1990·Granted Oct 27, 1992·13 cites·8 claims
- 0527US4853464AHybridoma cell line XMMBR-B14 and monoclonal antibody which is specific for a non-cross reactive epitope of CEAPERALTA CANCER RESEARCH INST·Filed 1988·Granted Aug 1, 1989·2 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when PERALTA CANCER RESEARCH INST files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →